3.570USD+5.94%Mkt Cap: 221.41M USDP/E: —Last update: 2026-06-01
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat live…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap221.41M USD
Enterprise Value187.98M USD
Revenue (TTM)44.88M USD
Gross Profit38.19M USD
Net Income (TTM)-39.23M USD
Revenue/Share1.024 USD
Last Price3.570 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees102
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-13.64
PEG—
EV/EBITDA-6.85
EV/Revenue4.19
P/S4.67
P/B-5.04
EPS (TTM)-1.42
EPS (Forward)-0.25
52W Range
2.20024% of range7.950
52W High7.950 USD
52W Low2.200 USD
Profitability
Gross Margin84.57%
Oper. Margin-94.52%
EBITDA Margin-61.13%
Profit Margin-86.88%
ROE115.85%
ROA-111.03%
Growth
Revenue Growth-2.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.01M USD
CapEx (TTM)918.00K USD
FCF Margin-20.73%
FCF Yield-4.20%
Net Debt-22.07M USD
Net Debt/EBITDA0.80
Balance Sheet
Debt/Equity-1.02
Current Ratio5.78
Quick Ratio5.24
Book Value/Sh-0.6770 USD
Cash/Share0.9210 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)8.800 USD
Target Range7.000 USD – 11.00 USD
# Analysts5
Ownership
Shares Out.61.42M
Float48.99M
Insiders33.91%
Institutions34.44%
Short Interest
Short Ratio3.0d
Short % Float3.62%
Short % Out.2.74%
Shares Short1.69M
Short (prev mo.)1.32M
Technical
SMA 504.003 (-10.8%)
SMA 2004.930 (-27.6%)
Beta0.56
S&P 52W Chg27.70%
Avg Vol (30d)531.37K
Avg Vol (10d)607.08K
Technical Indicators
RSI (14)43.4
MACD-0.2940
MACD Signal-0.2947
MACD Hist.+0.0007
BB Upper5.148 USD
BB Middle3.646 USD
BB Lower2.143 USD
BB Width82.41%
ATR (14)0.3312 USD
Vol Ratio (20d)0.26x